Authorized Generics Archives

U.S. Congress Proposes Bills to Strengthen Pharma Competition, Promote Innovation

Authorized Generics, Biosimilars, Branded Generics, Clinical Trials, Congress, Drug Price Reform, Drug Prices, Drug Pricing, Generic Substitution, Generics, House Committee on Oversight and Government Reform, Interchangeable Biosimilars, Pricing, R&D, R&D Investment Return

On Thursday, members of both the U.S. House of Representatives and the U.S. Senate introduced legislation that targets efforts that have limited competition, which keeps the price of prescription drugs high.

April 8, 2022/by BioSpace

Eli Lilly’s Generic Insulin Hits Market at Half the Price of Branded Counterpart

American Diabetes Association, Authorized Generics, Blockbusters, Generics, Health Care Cost Institute (HCCI), Injections, Insulin, Launches, Pricing, Therapeutics, Type 1 Diabetes

Indianapolis-based Eli Lilly announced that the company’s Lispro Injection, an authorized generic version of the life-saving insulin Humalog, is available at pharmacies at a 50 percent lower list price.

May 23, 2019/by BioSpace

AstraZeneca to Eliminate 700 U.S. Jobs

Authorized Generics, Beta Blockers, Business, Deals, Health, Job Cuts, Layoffs, Monoclonal Antibodies, People on the Move

Global pharmaceutical company AstraZeneca is delivering unwanted Christmas presents in the form of pink slips to 700 employees across the United States, with about 150 being terminated in Delaware.

December 9, 2016/by BioSpace

AstraZeneca Sells Crohn’s Drug Rights to Perrigo for $380 Million

Authorized Generics, Biopharma, Business, Consumer Goods, Crohn's Disease, Crohn's Disease, Crohn's Disease, Divestments, Divestments, Gastroenterology, Generics, Health, OTC, Sales, Therapeutics

AstraZeneca enters into agreement with Perrigo for rights to Entocort in the US Divestment further sharpens focus on three main therapy areas Agreement follows ex-US divestment of Entocort in July […]

November 23, 2015/by BioSpace